Tahir Aziz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tahir Aziz has a total of 145 co-authors. Here are the top co-authors by number of shared publications:
Abudu Momodu
1 shared publication- Adam B. King
Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee
1 shared publication - Adrian Newland
Department of Haematology, The Royal London Hospital, London, UK
1 shared publication - Aiysha Abid
Centre for Human Genetics and Molecular Medicine, Sindh Institute of Urology and Transplantation (SIUT), Karachi, Pakistan
1 shared publication Alan McDermott
1 shared publicationAlan Wakeman
1 shared publication
Latest Publications
- 23 February 2023
- Published by Wiley in Clinical Transplantation
- Vol. 37 (5) , e14935
Impact of pre‐transplant donor specific antibodies detected by Luminex with negative microlymphocytotoxicity assay and flow crossmatch in live‐related renal transplant recipients
Introduction/Aim: The Luminex assay, where beads are coated with a single HLA antigen, has been shown to detect HLA antibodies with more sensitivity and specificity as compared to microlymphocytotoxicity (CDC) assay and flow cross match (FCXM). We report the impact of low Mean Flourescence intensity (MFI) pre‐transplant DSA by Luminex with negative CDC and FCXM on acute rejection, graft function, and survival.Methods: In this retrospective study between January 2015 to December 2021, 45 recipients had pre‐transplant anti‐HLA donor‐specific antibodies (DSAs) detected by Luminex. Two control groups of 45 patients each matched for age and gender, first with non‐DSA HLA antibodies and second with no antibodies by Luminex were selected to compare outcomes with DSA group.Results: In the DSA group of 45, 22 (48.8%) had class I (MFI mean 4043 ± 1909, range: 1096–7111), 20 (44.4%) class II (MFI mean 3601 ± 2310, range: 1031–9259), and 3 (6.6%) both class I (MFI mean 4746 ± 1922) and class II (MFI mean 3940 ± 2312) antibodies. Acute rejection episodes were reported in 15.6%, DSA group, 17.8% in non‐DSA, and 24.4% in no antibody group (p = .538). Death censored graft survival at 1 and 5 years was 98% and 93% in DSA group, 100% and 95% in non‐DSA and 93% and 85% in the no antibody group (p = .254).Conclusions: Patients with low MFI DSA pre‐transplant, with a negative CDC and FCXM under ATG induction, have similar graft outcomes at 1 and 5 years when compared to non‐DSA and no antibody groups.
- 23 February 2023
- Published by Wiley in Clinical Transplantation
- Vol. 37 (5) , e14935
Impact of pre‐transplant donor specific antibodies detected by Luminex with negative microlymphocytotoxicity assay and flow crossmatch in live‐related renal transplant recipients
Introduction/Aim: The Luminex assay, where beads are coated with a single HLA antigen, has been shown to detect HLA antibodies with more sensitivity and specificity as compared to microlymphocytotoxicity (CDC) assay and flow cross match (FCXM). We report the impact of low Mean Flourescence intensity (MFI) pre‐transplant DSA by Luminex with negative CDC and FCXM on acute rejection, graft function, and survival.Methods: In this retrospective study between January 2015 to December 2021, 45 recipients had pre‐transplant anti‐HLA donor‐specific antibodies (DSAs) detected by Luminex. Two control groups of 45 patients each matched for age and gender, first with non‐DSA HLA antibodies and second with no antibodies by Luminex were selected to compare outcomes with DSA group.Results: In the DSA group of 45, 22 (48.8%) had class I (MFI mean 4043 ± 1909, range: 1096–7111), 20 (44.4%) class II (MFI mean 3601 ± 2310, range: 1031–9259), and 3 (6.6%) both class I (MFI mean 4746 ± 1922) and class II (MFI mean 3940 ± 2312) antibodies. Acute rejection episodes were reported in 15.6%, DSA group, 17.8% in non‐DSA, and 24.4% in no antibody group (p = .538). Death censored graft survival at 1 and 5 years was 98% and 93% in DSA group, 100% and 95% in non‐DSA and 93% and 85% in the no antibody group (p = .254).Conclusions: Patients with low MFI DSA pre‐transplant, with a negative CDC and FCXM under ATG induction, have similar graft outcomes at 1 and 5 years when compared to non‐DSA and no antibody groups.
- Open Access
- 1 October 2019
- Published by Elsevier in The Lancet Haematology
- Vol. 6 (10) , e510-e520
Longer-term efficiency and safety of increasing the frequency of whole blood donation (INTERVAL): extension study of a randomised trial of 20 757 blood donors
- 1 October 2019
- Published by Elsevier in The Lancet Haematology
- Vol. 6 (10) , e510-e520
Open AccessLonger-term efficiency and safety of increasing the frequency of whole blood donation (INTERVAL): extension study of a randomised trial of 20 757 blood donors
- 1 July 2018
- Published by Wolters Kluwer Health in Transplantation
- Vol. 102 (Supplement) , S505
Right Sided Laparoscopic Donor Nephrectomy - Dream Comes True
Introduction Laparoscopic donor nephrectomy is being progressively accepted with considerably decreased morbidity and favorable graft function. Controversy persists about whether procurement of the right kidney can be done successfully by the laparoscopic approach. To date, most laparoscopic live donor nephrectomies have been performed on the left side because the shorter length of the right renal vein poses technical challenges for the transplant surgeon in implanting the kidney into the recipient. Right-sided operation is technically more difficult and much more challenging because retraction of the liver is usually required and because the shorter right renal vein increases the risk of allograft thrombosis. Nevertheless, despite difficulties there are certain advantages like lack of draining venous tributaries which shorten the time of surgery. Objective To evaluate the outcomes of right sided laparoscopic donor nephrectomy in Pakistani kidney donors. Materials and methods We collected retrospective live donor nephrectomy data from Single center from May 2014 – Feb 2017. Demographics and hospital records were reviewed. Laparoscopic donor nephrectomy (RLDN) of right side was compared with left sided live related laparoscopic donor nephrectomy (LLDN). Demographic data was recorded in laparoscopic patients along with open donor group. Intra and post-operative events and complication were also analyzed. Finally the graft outcome was evaluated in right sided and left sided laparoscopic group. Results A total of 458 patients who had laparoscopic donor nephrectomy were included in this study. Right laparoscopic donor nephrectomy was done in 46 cases. Out of which 30 were male and 16 female. Mean hospital stay was 3 days and mean operative time was approximately 3 hours on right side. All grafts were primary functioning and there was satisfactory drop in Serum creatinine. Postoperative complications were noticed in two cases including cellulitis of abdominal wall and conversion in one case because of bleeding. Conclusions The results for laparoscopic donor nephrectomy were comparable to Right sided kidneys can be harvested safely laparoscopically with excellent donor outcome as well as comparable graft function with left sided laparoscopic and open group.
- 1 July 2018
- Published by Wolters Kluwer Health in Transplantation
- Vol. 102 (Supplement) , S505
Right Sided Laparoscopic Donor Nephrectomy - Dream Comes True
Introduction Laparoscopic donor nephrectomy is being progressively accepted with considerably decreased morbidity and favorable graft function. Controversy persists about whether procurement of the right kidney can be done successfully by the laparoscopic approach. To date, most laparoscopic live donor nephrectomies have been performed on the left side because the shorter length of the right renal vein poses technical challenges for the transplant surgeon in implanting the kidney into the recipient. Right-sided operation is technically more difficult and much more challenging because retraction of the liver is usually required and because the shorter right renal vein increases the risk of allograft thrombosis. Nevertheless, despite difficulties there are certain advantages like lack of draining venous tributaries which shorten the time of surgery. Objective To evaluate the outcomes of right sided laparoscopic donor nephrectomy in Pakistani kidney donors. Materials and methods We collected retrospective live donor nephrectomy data from Single center from May 2014 – Feb 2017. Demographics and hospital records were reviewed. Laparoscopic donor nephrectomy (RLDN) of right side was compared with left sided live related laparoscopic donor nephrectomy (LLDN). Demographic data was recorded in laparoscopic patients along with open donor group. Intra and post-operative events and complication were also analyzed. Finally the graft outcome was evaluated in right sided and left sided laparoscopic group. Results A total of 458 patients who had laparoscopic donor nephrectomy were included in this study. Right laparoscopic donor nephrectomy was done in 46 cases. Out of which 30 were male and 16 female. Mean hospital stay was 3 days and mean operative time was approximately 3 hours on right side. All grafts were primary functioning and there was satisfactory drop in Serum creatinine. Postoperative complications were noticed in two cases including cellulitis of abdominal wall and conversion in one case because of bleeding. Conclusions The results for laparoscopic donor nephrectomy were comparable to Right sided kidneys can be harvested safely laparoscopically with excellent donor outcome as well as comparable graft function with left sided laparoscopic and open group.
- Open Access
- 8 May 2018
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 53 (9) , 1228-1230
Trends and outcomes-first 100 bone marrow transplants at a Tertiary Care Center in Islamabad, Pakistan
- 8 May 2018
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 53 (9) , 1228-1230
Open AccessTrends and outcomes-first 100 bone marrow transplants at a Tertiary Care Center in Islamabad, Pakistan